Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems, Pharmo-Gene

Premium

Applied Biosystems has launched BioMonitor, a device that enables researchers to remotely monitor the ABI PRISM 3100, 3730, and 3730xl gene analyzers. The instrument, which is available to contract and warranty customers, allows ABI to remotely monitor and analyze the operational parameters from each instrument attached to the system. This, in turn, enables remote diagnostics and failure prediction.


Pharmo-Gene has released its Pharmo-Gene A polymer mirror microarray substrate in North America, and is looking for a commercialization partner. PGA substrates have a highly reflective backside surface that the company claims can increase signal-to-noise ratio on all fluorescent detection instruments. Pharmo-Gene currently sells the chips in China, Japan, and elsewhere in Asia.

Filed under

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.